Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV Virus
Trial status changed: Recruiting → Withdrawn
West China HospitalPhase 1 NCT06741982 Registry history of NCT06741982 on ClinicalTrials.gov (opens the registry)